What Public Policy Projects does

Public Policy Projects (PPP) is a London-based policy events, publishing, and advisory organisation operating within the Dorson Group and founded by former UK Secretary of State for Health Stephen Dorrell. The company convenes senior stakeholders across the UK health and care system and the global life sciences sector through nine programme areas spanning health, care, genomics, precision medicine, and health-tech policy. PPP monetises primarily through corporate partnership and sponsorship packages sold to more than 50 named partners across global pharma (Roche, GSK, AstraZeneca, Boehringer Ingelheim, Bayer, Sanofi), MedTech (Smith+Nephew, Coloplast, Mölnlycke), diagnostics (Fujifilm, Abbott, Dexcom), genomics (Wellcome Sanger Institute, GA4GH), and health technology (Oracle Health, Optum, Quantexa, CHIME International). The business is also a publisher, owning two vertical media brands — Hospital Times and Integrated Care Journal — that serve NHS, integrated care board, and life sciences audiences.

PPP's underlying technology footprint is modest and operationally oriented rather than product-led: the company uses Zoho for CRM, Brevo for email marketing, and custom publishing platforms to run its owned media properties. There is no proprietary AI, model, or platform product; the company's value proposition rests on convening power, editorial credibility, and access to senior policy-makers and industry executives. Its flagship Genomics and Precision Medicine Programme, now in its sixth year, has built a community of 1,000+ experts across 65+ countries, and PPP has extended internationally with the Abu Dhabi Department of Health partnership and the Stockholm-based Precision Medicine Europe Forum. The company employs approximately 24 people and operates as a privately held subsidiary within the Dorson Group.

Name

Public Policy Projects

Legal name

Public Policy Projects Ltd

Website

https://publicpolicyprojects.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Public Policy Projects is a London-based policy events, publishing, and advisory firm that convenes senior NHS, government, and global life sciences stakeholders across nine health and care programmes, monetising through corporate partnerships and two owned media brands, Hospital Times and Integrated Care Journal.

Ownership category

akta.pro rank

Product category

Health Policy Advisory Services

NAICS

Research and Development in the Social Sciences and Humanities (54172)

akta.pro primary industry

Public–Private Partnerships (PPPs) for Global Health (HLAJAOAD)

Keywords

• Health policy advisory
• Policy conferences events
• Independent policy reports
• NHS thought leadership
• Life sciences partnership programmes

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Event Sponsorship and Exhibition Packages: PPP generates revenue primarily through event sponsorship packages where pharma, MedTech, diagnostics, and genomics companies sponsor individual events or entire programmes. Sponsors receive logo placement on promotional materials, at events, and in PPP Insights and Reports. Sessions with sponsor input are marked on the programme.
2. Event Delegate Registrations: PPP sells delegate places at its conferences and forums. Registrations are made online or through account managers who issue a quote and sales order. Payment must be made within 30 days of the registration order.
3. PPP Publications (Hospital Times and Integrated Care Journal): PPP publishes content through its flagship journals Hospital Times and Integrated Care Journal, providing brand exposure and profile across the sector through media coverage and news commentary.
4. Partnership Packages: PPP offers a range of Partnership Packages designed to meet different client needs. Packages include speaker invitations, topic input for sponsored sessions, logo on promotional material, and inclusion in PPP Insights and Reports distributed to the stakeholder database.
5. Programme-Specific Grants and Sponsorship: PPP events are supported by the pharmaceutical and MedTech industries via Grants, Sponsorship, and Exhibition packages. For example, the Cancer Care Programme report 'No patient left behind' was funded by Boehringer Ingelheim.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Public Policy Projects (PPP) is an independent policy research and events organisation operating in the UK health, care, and life sciences sectors. It organises in-person conferences, invitation-only roundtables, and exclusive breakfast and dinner events across nine programme areas (Cancer Care, Data and Digital Transformation, Genomics and Precision Medicine, Integrated Care Delivery, Long-Term Conditions, Medicines and Pharmacy, Neighbourhood Health, Patient Safety, and Wound Care), and publishes independent reports (PPP Insights) and two flagship journals — Hospital Times and Integrated Care Journal. Revenue is generated primarily through event sponsorship, partnership packages, and delegate registrations from NHS, pharmaceutical, MedTech, and genomics organisations.

Product overview

Public Policy Projects (PPP) operates as a policy research and events organization in the health and life sciences sector, not a technology product company. PPP offers a portfolio of programmes covering Cancer Care, Data and Digital Transformation, Genomics and Precision Medicine, Integrated Care Delivery, Long-Term Conditions, Medicines and Pharmacy, Neighbourhood Health, Patient Safety, and Wound Care. Core services include organizing events (conferences, roundtables, breakfasts, dinners), publishing independent reports (PPP Insights and Reports), and maintaining flagship publications (Hospital Times and Integrated Care Journal). The portfolio is distributed through events, reports, and online publishing platforms, with a partner sponsorship programme for organizations seeking brand alignment with thought-leadership.

Differentiator

Problem solved

Functional benefit

Brands

• Hospital Times: Flagship journal publication covering hospital and NHS news and analysis
• Integrated Care Journal

Products and services

• PPP Events and Conferences In-person conferences, invitation-only roundtables, and exclusive breakfast and dinner events covering health policy topics including integrated care systems, health inequalities, precision medicine, and NHS Net Zero. Designed to bring together NHS leaders, pharmaceutical/MedTech executives, and third-sector stakeholders.
• PPP Insights and Reports Independent reports and online publishing highlighting practical recommendations identified from events and research, distributed to NHS leaders, policymakers, life sciences companies, and other stakeholders in the health and life sciences sectors.
• Hospital Times PPP's flagship journal covering hospital and NHS delivery news and analysis, distributed online and providing brand exposure and thought-leadership across the UK health sector.
• Integrated Care Journal PPP's journal focused on integrated care, ICS developments, and health system transformation, providing news and analysis to NHS and integrated care system leaders.
• PPP Partner Programme Partnership programme allowing organisations to sponsor events, roundtables, and reports, providing brand alignment with thought-leadership, logo placement on promotional materials, speaker invitations, topic input for sponsored sessions, and exposure to key decision-makers.
• Cancer Care Programme Programme exploring developments across cancer care to support collaborative approaches for effective NHS integration of innovative technologies, including the annual Cancer Care Conference and roundtable discussions on radiotherapy, SACT protocols, and equity in cancer treatment access.
• Data and Digital Transformation Programme Programme convening stakeholders to advance practical recommendations for digital and data-driven transformation across health and care services, including discussions on shared data environments, population health analytics, and NHS technology adoption.
• Genomics and Precision Medicine Programme Programme entering its 6th year, bringing together a global network of over 1,000 experts from more than 65 countries to improve genomics research, clinical implementation, data sharing frameworks, and precision medicine adoption.
• Integrated Care Delivery Forum Forum bringing together NHS reform leaders exploring repositioning of ICBs as strategic commissioners, AI, innovation, and medicines optimisation within integrated care systems.
• Long-Term Conditions Programme Programme addressing diabetes, cardiovascular disease, renal disease, obesity, and other chronic conditions with cross-sector collaboration focus, including digital tools and integrated care pathway design.
• Medicines and Pharmacy Programme Programme exploring how systems can reframe the value of medicines, adopt them responsibly, and embed pharmacy at the heart of neighbourhood-based care, including community pharmacy transformation, medicines optimisation, and digital pathway approaches.
• Neighbourhood Health Programme Engagement programme supporting the Neighbourhood Health Framework, focusing on practicalities of delivery with real-world route maps and case studies, remote patient monitoring, and connected care.
• Patient Safety Programme Collaboration with Patient Safety Learning to engage system leaders on improving patient safety culture within UK healthcare innovation, including discussions on healthcare governance, risk, and compliance.
• Wound Care Programme Programme uniting clinicians, industry, NHS leadership, and stakeholders to elevate wound healing as a strategic priority in British healthcare, supporting initiatives such as 'Going further for wound healing'.

Quantifiable outcome

• PPP events have delivered insights that contributed to shaping national health policy debates including the NHS 10-Year Health Plan and the National Cancer Plan.
• +2 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

44 partnerships are on record, tiered core and secondary.

• Amethyst Radiotherapy UKcoreStrategic or Co-development PartnerAmethyst Radiotherapy UK is a Cancer Care Programme Partner. CEO Sasha Burns participated in PPP's Cancer Care Conference 2025 panel on radiotherapy capacity. Amethyst is part of the broader oncology ecosystem that PPP convenes to address radiotherapy underfunding and underutilisation in the UK.
• CyTED HealthcoreStrategic or Co-development PartnerCyTED Health is listed as a Cancer Care Programme Partner. CyTED (Cyprus) works in health technology and is part of PPP's effort to bring international perspectives to UK cancer care debates.
• FujifilmcoreStrategic or Co-development PartnerFujifilm is listed as a Cancer Care Programme Partner. Fujifilm contributes to discussions on cancer diagnostics innovation, particularly around AI in radiology and imaging technology.
• InHealth GroupcoreStrategic or Co-development PartnerInHealth Group is listed as a Cancer Care Programme Partner, providing insights on diagnostic capacity expansion and community diagnostic centres.
• RochecoreStrategic or Co-development PartnerRoche is a Cancer Care Programme Partner and also a partner in the Medicines and Pharmacy Programme. Roche Pharmaceuticals and Roche Diagnostics contribute to discussions on cancer treatment access, SACT protocols, and precision medicine.
• AstraZenecacoreStrategic or Co-development PartnerAstraZeneca is a Programme Sponsor for the Genomics and Precision Medicine Programme 2026. AstraZeneca is listed alongside other genomics sponsors including Covaris, Hedera DX, Medicilon, Mission Bio, Pixelgen, Qiagen, and Sophia Genetics.
• Wellcome Sanger InstitutecoreStrategic or Co-development PartnerWellcome Sanger Institute is a PPP Partner and a leading global genomics research institution. It participates in PPP's genomics programme discussions on clinical implementation and research environments.
• Global Alliance for Genomics and Health (GA4GH)coreStrategic or Co-development PartnerGA4GH is a PPP Partner contributing to discussions on genomic data sharing standards, interoperability, and the global policy framework for genomics implementation.
• Genomic Medicine SwedensecondaryStrategic or Co-development PartnerGenomic Medicine Sweden is a Programme Sponsor for the Genomics and Precision Medicine Programme 2026, representing the Nordic genomics ecosystem alongside Oslo Cancer Cluster and SciLifeLab.
• Oslo Cancer ClustersecondaryStrategic or Co-development PartnerOslo Cancer Cluster is a Programme Sponsor for the Genomics and Precision Medicine Programme 2026, contributing to cross-border genomics and oncology discussions.
• SciLifeLabsecondaryStrategic or Co-development PartnerSciLifeLab (Science for Life Laboratory, Sweden) is a Programme Sponsor for the Genomics and Precision Medicine Programme 2026, bringing academic and research perspectives to PPP's genomics debates.
• AlcidioncoreStrategic or Co-development PartnerAlcidion is listed as a partner for both the Data and Digital Transformation Programme and the Integrated Care Delivery Forum. Alcidion provides EPR and digital health solutions, contributing to discussions on NHS digital transformation and patient flow.
• Orion HealthcoreStrategic or Co-development PartnerOrion Health is a partner for the Data and Digital Transformation Programme and Integrated Care Delivery Forum. Orion Health contributes to discussions on shared data environments, population health analytics, and integrated care technology.
• QuantexacoreStrategic or Co-development PartnerQuantexa is a partner for the Data and Digital Transformation Programme and Integrated Care Delivery Forum. PPP extended its Strategic Partnership with Quantexa to accelerate neighbourhood data connectivity across ICS systems.
• Data 4 NHSsecondaryStrategic or Co-development PartnerData 4 NHS is listed as a partner for the Integrated Care Delivery Forum, providing data solutions and insights for NHS digital and data transformation.
• NECsecondaryStrategic or Co-development PartnerNEC (Healthcare Software) is a partner for the Integrated Care Delivery Forum, contributing to discussions on digital infrastructure and NHS technology adoption.
• Duet DiabetescoreStrategic or Co-development PartnerDuet Diabetes is a Programme Partner for the Long-Term Conditions Programme, contributing to discussions on diabetes care transformation, digital tools, and integrated care pathways.
• InsuletcoreStrategic or Co-development PartnerInsulet (maker of Omnipod insulin pumps) is a Programme Partner for the Long-Term Conditions Programme, contributing to diabetes technology and care pathway discussions.
• OvivacoreStrategic or Co-development PartnerOviva is a Programme Partner for the Long-Term Conditions Programme, providing digital health solutions for diabetes and obesity care management.
• TunstallcoreStrategic or Co-development PartnerTunstall is the Headline Partner for the Neighbourhood Health Programme, providing technology for remote patient monitoring and connected care that enables neighbourhood health delivery.
• Home GroupcoreStrategic or Co-development PartnerHome Group is a Programme Partner for the Neighbourhood Health Programme, contributing housing and social care perspectives to neighbourhood health discussions.
• MaydensecondaryStrategic or Co-development PartnerMayden is a Programme Partner for the Neighbourhood Health Programme, providing digital health platform solutions for community-based care.
• Mills & ReevesecondaryStrategic or Co-development PartnerMills & Reeve is a Programme Partner for the Neighbourhood Health Programme, providing legal and advisory perspectives on health policy and commissioning.
• NHS Property ServicescoreStrategic or Co-development PartnerNHS Property Services is a Programme Partner for the Neighbourhood Health Programme, contributing expertise on NHS estates, capital funding, and the physical infrastructure needed for neighbourhood health delivery.
• Patient Safety LearningcoreStrategic or Co-development PartnerPatient Safety Learning is a unique collaborator in PPP's Patient Safety Programme. Both organisations have established track records engaging with system leaders. PPP leverages Patient Safety Learning's networks to convene an influential audience for patient safety discussions.
• Smith+NephewcoreStrategic or Co-development PartnerSmith+Nephew is a Programme Partner for the Wound Care Programme. Smith+Nephew supports PPP's 'Going further for wound healing' initiatives and events, helping shape what's possible in wound care and driving reform.
• MölnlyckecoreStrategic or Co-development PartnerMölnlycke is a PPP Partner supporting the Wound Care Programme. Mölnlycke's Strategic Partnership team contributes insights on wound care strategies that support NHS goals.
• Flen HealthsecondaryStrategic or Co-development PartnerFlen Health is a Programme Partner for the Wound Care Programme, providing wound care products and expertise to PPP's wound healing reform initiatives.
• PolyNovosecondaryStrategic or Co-development PartnerPolyNovo is a Programme Partner for the Wound Care Programme, contributing to discussions on wound care innovation and NHS adoption of advanced wound care products.
• AbbottcoreStrategic or Co-development PartnerAbbott is a PPP Partner in the pharma/MedTech category, contributing to health policy discussions across PPP's programme areas.
• Association of British HealthTech Industries (ABHI)coreStrategic or Co-development PartnerABHI is a PPP Partner, representing the UK HealthTech industry and contributing to PPP's policy debates on innovation adoption and NHS procurement.
• Abu Dhabi Department of HealthcoreStrategic or Co-development PartnerAbu Dhabi Department of Health is a PPP Partner, participating in PPP's genomics and precision medicine discussions. PPP published a report exploring Abu Dhabi's health and life sciences strategy for genomics and precision medicine.
• BayercoreStrategic or Co-development PartnerBayer is a PPP Partner in the pharmaceutical sector, contributing to health policy debates across PPP's programmes including cancer care and precision medicine.
• Boehringer IngelheimcoreStrategic or Co-development PartnerBoehringer Ingelheim is a PPP Partner and funder of the report 'No patient left behind: driving equity in cancer treatment access', co-authored with Macmillan Cancer Support. Boehringer actively participates in PPP's Cancer Care roundtable programme.
• GSKcoreStrategic or Co-development PartnerGSK is a PPP Partner contributing to PPP's health policy debates, particularly in areas relevant to vaccines, infectious diseases, and oncology.
• SanoficoreStrategic or Co-development PartnerSanofi is a PPP Partner in the pharmaceutical sector, participating in health policy discussions across PPP's programmes.
• DexcomcoreStrategic or Co-development PartnerDexcom is a PPP Partner providing continuous glucose monitoring technology perspectives to the Long-Term Conditions and diabetes care discussions.
• Oracle HealthcoreTechnology or IntegrationOracle Health is a PPP Partner contributing to the Data and Digital Transformation Programme and Patient Safety Programme. Oracle Health's electronic health record and data solutions are featured in PPP's digital NHS discussions.
• OptumcoreStrategic or Co-development PartnerOptum is a PPP Partner contributing analytical, technology, and advisory expertise to PPP's integrated care and digital transformation discussions.
• Australian GenomicscoreStrategic or Co-development PartnerAustralian Genomics is a PPP Partner contributing international perspectives on genomics policy, clinical implementation, and data sharing frameworks.
• Silver BucksecondaryGTM or Marketing PartnerSilver Buck is a PPP Event Partner — a digital health PR, communications and marketing agency that supports PPP's outreach. Silver Buck serves as the go-to digital health PR agency for PPP's ecosystem, working with start-ups, NHS trusts, ICS organisations, and government bodies.
• CHIME InternationalcoreStrategic or Co-development PartnerCHIME International partnered with PPP on a roundtable examining why fragmented data continues to limit NHS digital transformation, producing the report 'Why data coherence will define whether NHS digital transformation succeeds', sponsored by RLDatix.
• RLDatixcoreStrategic or Co-development PartnerRLDatix provided sponsorship for the PPP-CHIME International roundtable on NHS data fragmentation. RLDatix contributes to PPP's patient safety and data quality discussions as a healthcare governance, risk, and compliance software provider.
• London Institute for Healthcare Engineering (LIHE)coreStrategic or Co-development PartnerLIHE established a new partnership with PPP to convene leaders from across the medtech ecosystem to generate practical, policy-relevant outputs from structured discussion. LIHE co-hosted a breakfast discussion on the future of medtech adoption in the NHS.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• The King's Fund: Independent health-policy think tank producing influential reports, roundtables, and events on NHS reform. Comparable because both organisations convene senior NHS/policy stakeholders, publish independent analysis, and shape UK health-policy debate.
• The Health Foundation: Independent charity funding health-care research and improvement, producing influential policy analysis. Comparable as a peer think-tank/policy-publisher in UK health care, although its funding model is grant-based rather than sponsorship-led.
• NHS Confederation: Membership body representing NHS organisations, running conferences and policy programmes on integrated care, leadership, and system reform. Comparable as a direct competitor for NHS-executive attention and event sponsorship.
• Nuffield Trust: Independent health-research charity producing evidence-based reports and events on NHS performance and reform. Comparable because it occupies the same 'independent voice shaping UK health policy' positioning PPP claims.
• Health Service Journal (HSJ): UK's leading subscription news and events brand for NHS leaders. Directly comparable because it monetises NHS-executive audiences through paid subscriptions, sponsored events, and awards — a business model PPP emulates with Hospital Times and its conference portfolio.

Broad incumbents

• HIMSS: Global not-for-profit focused on health-information technology, with major conferences (HIMSS Global) and policy programmes. Comparable as a larger, global convener on health-IT and digital transformation — overlapping with PPP's Data and Digital Transformation Programme.
• Reuters Events (Healthcare): B2B events arm of Reuters running large pharma/healthcare industry summits. Comparable as a broader incumbent offering sponsored industry events targeting pharma executives — overlapping with PPP's enterprise-sponsorship GTM.
• Wilmington Healthcare (Wilmington plc): Division of listed Wilmington plc providing data, insight, and events to pharma and MedTech engaging with the NHS. Comparable as a broader incumbent operating in pharma-NHS market-access intelligence, events, and training — overlapping with PPP's commercial value proposition for partners.
• Cogora: B2B media and events group publishing healthcare titles (e.g. Nursing in Practice, Hospital Healthcare Europe) and running conferences. Comparable because it combines healthcare publishing with paid industry events — the same dual model PPP uses with Hospital Times/Integrated Care Journal plus conferences.

Others

• ABPI (Association of the British Pharmaceutical Industry): UK pharma industry trade association representing member companies on policy, NHS engagement, and code-of-practice. Comparable as an ecosystem participant — ABPI is both a potential partner and a competitor for pharma-policy thought-leadership engagement in the UK.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/Policy_Projects
• LinkedInlinkedin.com/company/public-policy-projects

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Public Policy Projects